|
239-876-6
|
15780-33-3
|
Carc. 1A; STOT RE 1; Skin Sens. 1
|
|
|
|
Details
|
|
238-032-4
|
14177-51-6
|
Carc. 1A; STOT RE 1; Skin Sens. 1
|
|
|
|
Details
|
|
274-755-1
|
70692-93-2
|
Carc. 1A; STOT RE 1; Skin Sens. 1
|
|
|
|
Details
|
|
242-533-3
|
18721-51-2
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
287-468-1
|
85508-43-6
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
249-555-2
|
29317-63-3
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
287-469-7
|
85508-44-7
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
300-094-6
|
93920-10-6
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
300-093-0
|
93920-09-3
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
225-656-7
|
4995-91-9
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Skin Corr. 1A; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
237-138-8
|
13654-40-5
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
222-102-6
|
3349-08-4
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
233-263-7
|
10101-96-9
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
244-578-4
|
21784-78-1
|
Carc. 1A; STOT RE 1; Skin Sens. 1
|
|
|
|
Details
|
|
218-744-1
|
2223-95-2
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
231-827-7
|
7757-95-1
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
240-235-8
|
16083-14-0
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
231-111-4
|
7440-02-0
|
Carc. 2; STOT RE 1; Skin Sens. 1
|
|
|
|
Details
|
|
231-111-4
|
7440-02-0
|
Carc. 2; STOT RE 1; Skin Sens. 1
|
|
|
|
Details
|
|
200-193-3
|
54-11-5
|
|
|
|
|
Details
|
|
231-714-2
|
7697-37-2
|
Acute Tox. 1; Skin Corr. 1A
|
|
|
|
Details
|
|
231-714-2
|
7697-37-2
|
Acute Tox. 3; Skin Corr. 1A
|
|
|
|
Details
|
|
238-076-4
|
14216-75-2
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
DABCO X-412
|
413-670-8
|
103969-79-5
|
|
|
|
|
Details
|
|
202-716-0
|
98-95-3
|
Carc. 2; Repr. 1B; Acute Tox. 3; STOT RE 1
|
|
|
|
Details
|
|
217-406-0
|
1836-75-5
|
|
|
|
|
Details
|
|
233-272-6
|
10102-44-0
|
Acute Tox. 2; Skin Corr. 1B
|
|
|
|
Details
|
|
210-698-0
|
621-64-7
|
|
|
|
|
Details
|
|
-
|
60999-18-0
|
|
|
|
|
Details
|
|
206-400-3
|
335-76-2
|
|
|
|
|
Details
|
|
246-672-0
|
25154-52-3
|
|
|
|
|
Details
|
VULKANISATIONSBESCHLEUNIGER VP KA 9124
|
404-380-2
|
110799-28-5
|
|
|
|
|
Details
|
ASIL-322; OS-5200
|
421-870-1
|
156145-66-3
|
|
|
|
|
Details
|
|
227-534-9
|
5873-54-1
|
Carc. 2; STOT RE 2; Resp. Sens. 1; Skin Sens. 1
|
|
|
|
Details
|
|
202-423-8
|
95-48-7
|
Acute Tox. 3; Skin Corr. 1B
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
|
Details
|
|
218-276-8
|
2104-64-5
|
Acute Tox. 1; Acute Tox. 2
|
|
|
|
Details
|
ETA; ETA 50 (50 %IGE ZUBEREITUNG); O-ETHYLHYDROXYLAMINE
|
402-030-3
|
624-86-2
|
Flam. Liq. 2; Acute Tox. 3; STOT RE 1; Skin Sens. 1
|
|
|
|
Details
|
|
432-750-3
|
109202-58-6
|
Carc. 1B; Muta. 1B; STOT RE 2; Skin Sens. 1
|
|
|
|
Details
|
|
434-350-4
|
103122-66-3
|
Carc. 1B; Muta. 1B; STOT RE 2; Skin Sens. 1
|
|
|
|
Details
|
|
201-855-4
|
88-74-4
|
|
|
|
|
Details
|
|
202-430-6
|
95-54-5
|
Carc. 2; Muta. 2; Acute Tox. 3; Skin Sens. 1
|
|
|
|
Details
|
|
210-418-7
|
615-28-1
|
Carc. 2; Muta. 2; Acute Tox. 3; Skin Sens. 1
|
|
|
|
Details
|
|
-
|
-
|
|
|
|
|
Details
|
|
202-429-0
|
95-53-4
|
|
|
|
|
Details
|
|
204-695-3
|
124-30-1
|
|
|
|
|
Details
|
|
203-892-1
|
111-65-9
|
|
|
|
|
Details
|
|
204-677-5
|
124-07-2
|
|
|
|
|
Details
|
PROCION BRILLIANT ORANGE H-EXL; S156745
|
412-960-1
|
148878-21-1
|
|
|
|
|
Details
|
|
247-761-7
|
26530-20-1
|
Acute Tox. 2; Acute Tox. 3; Skin Sens. 1A
|
|
|
|
Details
|
|
|
|
|
|
|
|
|